RIVELTIN

Medicinal product

(Invented) name

RIVELTIN

Active substance (s)

Natrio chloridas/Kalio chloridas/Kalcio chloridas dihidratas/Magnio chloridas heksahidratas/Natrio acetatas trihidratas

Strength

5,26 g/0,37 g/0,37 g/0,3 g/6,8 g/1000 ml

Pharmaceutical form

infuzinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

B05BB01, Electrolytes

Marketing authorisation holder

VIOSER S.A. Parenteral Solutions Industry, Graikija

Date of authorisation

2024-07-24

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

LT/H/0185/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1000 ml tirpalo sudėtis:	1000 ml
Natrio chloridas	5,26 g
Kalio chloridas	0,37 g
Kalcio chloridas dihidratas	0,37 g
Magnio chloridas heksahidratas	0,3 g
Natrio acetatas trihidratas	6,8 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
114274	100386	1100386	buteliukas	500 ml N1	Receptinis	LT/1/24/5504/001	Netiekiama	-	-	No	-	-
114275	100387	1100387	buteliukas	500 ml N10	Receptinis	LT/1/24/5504/002	Netiekiama	-	-	No	-	-
114276	100388	1100388	buteliukas	1000 ml N1	Receptinis	LT/1/24/5504/003	Netiekiama	-	-	No	-	-
114277	100389	1100389	buteliukas	1000 ml N10	Receptinis	LT/1/24/5504/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-24	Registruotas